|
This is the vaccine I received, it was identified in the consent form as
"Phase I-II Study of Combination Immunotherapy for the Generation of HER-2/neu Specific CytotoxicT Cells (CTL) in vivo"
I was told they had very promising results from the Phase I, so it's exciting to see the actual length of time for immuntiy.
Although I have recurred since receiving the vaccine, my oncologist and I both believe the vaccine has been a factor in keeping the recurrence contained in my lymph nodes. That's a big, big plus as far as I'm concerned!
<3 Lolly
|